Nevro Priced, NYSE: NVRO
Awaiting approval for an implanted electrical device that treats leg and back pain.
Industry: Health Care
First Day Return: +39.9%
NVRO
Awaiting approval for an implanted electrical device that treats leg and back pain.
| IPO Data | |
|---|---|
| IPO Date | 11/05/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $126 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Menlo Park, CA, United States |
| Founded | 2006 |
| Employees at IPO | 114 |
| Website www.nevro.com | |
Nevro (NVRO) Performance
